Your activity: 62 p.v.
Why UpToDate?
What's New
Patient Education
Calculators
Drug interactions
Subscribe
Log In
< Back
your limit has been reached. plz
Donate
us to allow your ip full access, Email: sshnevis@outlook.com
Uptodate Reference Title
Go To Link
Close
Mean change ± standard deviation in A1C and body weight in patients with type 1 diabetes treated with insulin plus either pramlintide or placebo
Mean change ± standard deviation in A1C and body weight in patients with type 1 diabetes treated with insulin plus either pramlintide or placebo
A1C: glycated hemoglobin.
* p<0.05.
¶ p<0.001.
Reproduced with permission from: Buse J, Weyer C, Maggs D. Amylin replacement with pramlintide in type 1 and type 2 diabetes: A physiological approach to overcome barriers with insulin therapy. Clinical Diabetes 2002; 20:137. Copyright © 2002 The American Diabetes Association.
Graphic 79842 Version 3.0
